Quelicin Injection (Advanced Pharma) – Sterility Failure (2017)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
QUELICIN (Succinylcholine Chloride) Injection, USP 20 mg/mL in a) 5 mL vial (NDC 15082-814-67), b) 7mL vial (NDC 15082-814-79), c) 10mL vial (NDC 15082-814-61), Repackaged by Advanced Pharm, 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404.
Brand
Advanced Pharma Inc.
Lot Codes / Batch Numbers
Lot #: a) 5/15/17 2305 81467S, BUD 7/29/2017, 5/22/17 1000 81467S, BUD 8/5/2017, 5/30/17 1549 81467S, BUD 8/13/2017. b) 5/24/17 0307 169-81479S, BUD 7/23/2017, 5/18/17 0220 169-81479S, BUD 7/17/2017, 5/16/17 0306 169-81479S, BUD 7/15/2017, 6/5/17 0937 169-81479S, BUD 8/04/2017, 5/16/17 0314 445-81479S, BUD 7/15/2017, 5/16/17 0315 493-81479S, BUD 7/15/2017, c) 5/15/17 2119 81461S, BUD 7/29/2017, 5/22/17 0922 81461S, BUD 8/5/2017, 5/30/17 1533 81461S, BUD 8/13/2017, 6/12/17 1846 81461S, BUD 8/26/2017, 6/5/17 0237 157-81461SB, BUD 8/4/2017.
Products Sold
Lot #: a) 5/15/17 2305 81467S, BUD 7/29/2017; 5/22/17 1000 81467S, BUD 8/5/2017; 5/30/17 1549 81467S,BUD 8/13/2017. b) 5/24/17 0307 169-81479S, BUD 7/23/2017; 5/18/17 0220 169-81479S, BUD 7/17/2017; 5/16/17 0306 169-81479S, BUD 7/15/2017; 6/5/17 0937 169-81479S, BUD 8/04/2017; 5/16/17 0314 445-81479S, BUD 7/15/2017; 5/16/17 0315 493-81479S, BUD 7/15/2017; c) 5/15/17 2119 81461S, BUD 7/29/2017; 5/22/17 0922 81461S, BUD 8/5/2017; 5/30/17 1533 81461S, BUD 8/13/2017; 6/12/17 1846 81461S, BUD 8/26/2017; 6/5/17 0237 157-81461SB, BUD 8/4/2017.
Advanced Pharma Inc. is recalling QUELICIN (Succinylcholine Chloride) Injection, USP 20 mg/mL in a) 5 mL vial (NDC 15082-814-67), b) 7 due to Lack of Assurance of Sterility. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Lack of Assurance of Sterility
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026